2017
DOI: 10.18632/oncotarget.17278
|View full text |Cite
|
Sign up to set email alerts
|

Prox1 represses IL-2 gene expression by interacting with NFAT2

Abstract: Interleukin-2 (IL-2) is critical for T lymphocyte activation and regulated by many transcriptional factors. Prospero-related homeobox 1 (Prox1) is a multifunctional transcription factor, which can work as either a transcriptional activator or repressor depending on the cellular and developmental environment. We previously reported the Prox1 expression in T cells, raising the possibility of Prox1 involvement in the regulation of T cell function and IL-2 production. Here we demonstrated that the Prox1 expression… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 39 publications
0
4
0
Order By: Relevance
“…We also found several TFs that have not yet been associated but have been predicted to regulate differentiation in the same lineage as their target cytokines. For example, ELF3 was predicted in neutrophil differentiation based on its expression patterns during differentiation ( 84 ), and PROX1 was predicted to play a role in CD4+ T cell differentiation by suppressing key lineage cytokines ( 85 ). Overall, the lineage-associated PDI networks, generated from cytokines associated with abnormalities in lineage-specific differentiation, identified many TF interactors found by eY1H assays that have themselves been associated with differentiation of the same cell lineage.…”
Section: Resultsmentioning
confidence: 99%
“…We also found several TFs that have not yet been associated but have been predicted to regulate differentiation in the same lineage as their target cytokines. For example, ELF3 was predicted in neutrophil differentiation based on its expression patterns during differentiation ( 84 ), and PROX1 was predicted to play a role in CD4+ T cell differentiation by suppressing key lineage cytokines ( 85 ). Overall, the lineage-associated PDI networks, generated from cytokines associated with abnormalities in lineage-specific differentiation, identified many TF interactors found by eY1H assays that have themselves been associated with differentiation of the same cell lineage.…”
Section: Resultsmentioning
confidence: 99%
“…We also found several TFs that have not yet been associated but have been predicted to regulate differentiation in the same lineage as their target cytokines. For example, ELF3 was predicted in neutrophil differentiation based on its expression patterns during differentiation (Lee et al, 2015), and PROX1 was predicted to play a role in CD4+ T cell differentiation by suppressing key lineage cytokines (Zhang et al, 2017). Overall, the lineage-associated PDI networks generated from cytokines associated with abnormalities in lineage-specific differentiation, identified many TF interactors found by eY1H assays that have themselves been associated with differentiation in the same lineage.…”
Section: Identification Of Lineage Tfs Regulating Cytokine Genesmentioning
confidence: 99%
“…Prox1 regulates different target genes by forming complexes with other transcription factors, including NFATs and KLFs, in T cells and lymphatic ECs respectively. 33–35 Similarly, we identified NFAT and KLF binding sites near the V5-tagged binding sites in NFATc1 enCre Prox1 GoF VECs. Cx37, Efnb2, Flt1, and Egfl7 have known roles in either the development of the lymphatic system and cardiac valves and are highly differentially expressed in the Lymph-VEC population.…”
Section: Discussionmentioning
confidence: 71%
“…26,33 Interestingly, this revealed an enrichment of KLF and NFAT motifs, proteins previously shown to physically interact with Prox1 (Figure 4G). 34,35 Next, we sought to validate whether exemplar Prox1 bound genes were also induced by Prox1 in valve ECs. We focused on Connexin 37 (Cx37/Gja4 ), a known direct target of Prox1 in lymphatic valve ECs, which also has active enhancer signatures in wild-type VECs (Figure 4E).…”
Section: Resultsmentioning
confidence: 99%